 |
 |

QRS Duration in Patients Hospitalized for Worsening Heart Failure
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their study of hospitalization for heart failure with reduced left ventricular ejection fraction, Dr Wang and colleagues1 found that a prolonged baseline QRS duration was an independent predictor of high postdischarge morbidity and mortality. They also observed that patients who experienced a change in QRS duration during hospitalization had an increased rate of end points.
The authors noted that several studies have linked serial incremental changes in QRS duration to an increase in adverse cardiac events. In these studies, the serial electrocardiograms (ECGs) were performed at separate time points over a period of months, but the period in the study by Wang et al was shorter-term (10 days or less). Incremental prolongation of QRS duration over months has been demonstrated to be closely correlated with deterioration of left ventricular systolic and diastolic function, resulting in worse prognosis.2 However, it is uncertain whether variance of QRS duration . . . [Full Text of this Article]
Mao Chen, PhD, MD
hmaochen@vip.sina.com Department of Cardiology West China Hospital, Sichuan University Chengdu, China
Chang Huo, MBBS
Department of Internal Medicine No. 4 Hospital of Sichuan Province Chengdu, China
De-jia Huang, MD
Department of Cardiology West China Hospital, Sichuan University
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Clinical Implications of QRS Duration in Patients Hospitalized With Worsening Heart Failure and Reduced Left Ventricular Ejection Fraction
Norman C. Wang, Aldo P. Maggioni, Marvin A. Konstam, Faiez Zannad, Holly B. Krasa, John C. Burnett, Jr, Liliana Grinfeld, Karl Swedberg, James E. Udelson, Thomas Cook, Brian Traver, Christopher Zimmer, Cesare Orlandi, Mihai Gheorghiade, and for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
JAMA. 2008;299(22):2656-2666.
ABSTRACT
| FULL TEXT
RELATED LETTERS
QRS Duration in Patients Hospitalized for Worsening Heart Failure
Peter Höglund and L. A. Fredrik Nilsson
JAMA. 2008;300(16):1879-1880.
EXTRACT
| FULL TEXT
QRS Duration in Patients Hospitalized for Worsening Heart Failure
Abdul Hakeem, Sabha Bhatti, and Zainab Samad
JAMA. 2008;300(16):1880.
EXTRACT
| FULL TEXT
QRS Duration in Patients Hospitalized for Worsening Heart Failure—Reply
Mihai Gheorghiade, Norman C. Wang, and Thomas Cook
JAMA. 2008;300(16):1880-1881.
EXTRACT
| FULL TEXT
|